Diane K Wysowski

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. doi request reprint Use of parenteral iron products and serious anaphylactic-type reactions
    Diane K Wysowski
    Office of Surveillance and Epidemiology, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA
    Am J Hematol 85:650-4. 2010
  2. ncbi request reprint Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action
    Diane K Wysowski
    Division of Drug Risk Evaluation, Food and Drug Administration, White Oak, Bldg 22, Room 3424, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA
    Arch Intern Med 167:1414-9. 2007
  3. ncbi request reprint Reports of death with use of propofol (Diprivan) for nonprocedural (long-term) sedation and literature review
    Diane K Wysowski
    Division of Drug Risk Evaluation, Office of Surveillance and Epidemiology, Food and Drug Administration, Silver Spring, Maryland 20993, USA
    Anesthesiology 105:1047-51. 2006
  4. ncbi request reprint Use of medications for erectile dysfunction in the United States, 1996 through 2001
    Diane K Wysowski
    Office of Drug Safety, Food and Drug Administration, Rockville, Maryland, USA
    J Urol 169:1040-2. 2003
  5. ncbi request reprint Surveillance of prescription drug-related mortality using death certificate data
    Diane K Wysowski
    Division of Drug Risk Evaluation, Food and Drug Administration, Silver Spring, Maryland 20993, USA
    Drug Saf 30:533-40. 2007
  6. ncbi request reprint Trends in outpatient prescription drug use and related costs in the US: 1998-2003
    Diane K Wysowski
    Division of Drug Risk Evaluation, Food and Drug Administration, Rockville, Maryland, USA
    Pharmacoeconomics 24:233-6. 2006
  7. ncbi request reprint Use of menopausal hormones in the United States, 1992 through June, 2003
    Diane K Wysowski
    Division of Drug Risk Evaluation, Office of Drug Safety, Food and Drug Administration, Rockville, MD 20857, USA
    Pharmacoepidemiol Drug Saf 14:171-6. 2005
  8. ncbi request reprint Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions
    Diane K Wysowski
    Office of Drug Safety, Food and Drug Administration, Rockville, MD 20857, USA
    Arch Intern Med 165:1363-9. 2005
  9. ncbi request reprint Deaths attributed to X-ray contrast media on U.S. death certificates
    Diane K Wysowski
    Division of Drug Risk Evaluation, Food and Drug Administration, HFD 433, Silver Spring, MD 20993, USA
    AJR Am J Roentgenol 186:613-5. 2006
  10. ncbi request reprint Comparison of reported and expected deaths in sildenafil (Viagra) users
    Diane K Wysowski
    Office of Drug Safety, Food and Drug Administration, Rockville, MD 20857, USA
    Am J Cardiol 89:1331-4. 2002

Collaborators

  • Parivash Nourjah
  • James L Mills
  • Stephen J Durako
  • Paul Brown
  • Christopher Cox
  • Lawrence B Schonberger
  • Judith E Fradkin
  • Fanhui Kong

Detail Information

Publications15

  1. doi request reprint Use of parenteral iron products and serious anaphylactic-type reactions
    Diane K Wysowski
    Office of Surveillance and Epidemiology, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA
    Am J Hematol 85:650-4. 2010
    ..To help differentiate risk among the parenteral iron products, the brand name of the product always should be provided on medical records, death certificates, and adverse drug reaction reports...
  2. ncbi request reprint Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action
    Diane K Wysowski
    Division of Drug Risk Evaluation, Food and Drug Administration, White Oak, Bldg 22, Room 3424, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA
    Arch Intern Med 167:1414-9. 2007
    ..Warfarin sodium is widely used and causes bleeding; a review might suggest the need for regulatory action by the US Food and Drug Administration (FDA)...
  3. ncbi request reprint Reports of death with use of propofol (Diprivan) for nonprocedural (long-term) sedation and literature review
    Diane K Wysowski
    Division of Drug Risk Evaluation, Office of Surveillance and Epidemiology, Food and Drug Administration, Silver Spring, Maryland 20993, USA
    Anesthesiology 105:1047-51. 2006
  4. ncbi request reprint Use of medications for erectile dysfunction in the United States, 1996 through 2001
    Diane K Wysowski
    Office of Drug Safety, Food and Drug Administration, Rockville, Maryland, USA
    J Urol 169:1040-2. 2003
    ..MATERIALS AND METHODS Two pharmaceutical research data bases, the National Prescription Audit Plus, and National Disease and Therapeutic Index, were accessed and analyzed. Ancillary data were obtained from 2 health plans...
  5. ncbi request reprint Surveillance of prescription drug-related mortality using death certificate data
    Diane K Wysowski
    Division of Drug Risk Evaluation, Food and Drug Administration, Silver Spring, Maryland 20993, USA
    Drug Saf 30:533-40. 2007
    ..The prescription drugs or drug classes that are most frequently associated with death in the US might be identifiable from death certificate data...
  6. ncbi request reprint Trends in outpatient prescription drug use and related costs in the US: 1998-2003
    Diane K Wysowski
    Division of Drug Risk Evaluation, Food and Drug Administration, Rockville, Maryland, USA
    Pharmacoeconomics 24:233-6. 2006
    ..To present a brief synopsis of trends in the number of prescriptions and retail costs of outpatient drugs dispensed in the US between 1998 and 2003...
  7. ncbi request reprint Use of menopausal hormones in the United States, 1992 through June, 2003
    Diane K Wysowski
    Division of Drug Risk Evaluation, Office of Drug Safety, Food and Drug Administration, Rockville, MD 20857, USA
    Pharmacoepidemiol Drug Saf 14:171-6. 2005
    ....
  8. ncbi request reprint Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions
    Diane K Wysowski
    Office of Drug Safety, Food and Drug Administration, Rockville, MD 20857, USA
    Arch Intern Med 165:1363-9. 2005
    ..The Adverse Event Reporting System is the primary surveillance database used by the Food and Drug Administration for identifying postmarketing drug safety problems...
  9. ncbi request reprint Deaths attributed to X-ray contrast media on U.S. death certificates
    Diane K Wysowski
    Division of Drug Risk Evaluation, Food and Drug Administration, HFD 433, Silver Spring, MD 20993, USA
    AJR Am J Roentgenol 186:613-5. 2006
    ..S. death certificates and to attempt to assess the comparative safety of commonly used diagnostic X-ray contrast agents using death certificate information...
  10. ncbi request reprint Comparison of reported and expected deaths in sildenafil (Viagra) users
    Diane K Wysowski
    Office of Drug Safety, Food and Drug Administration, Rockville, MD 20857, USA
    Am J Cardiol 89:1331-4. 2002
  11. ncbi request reprint Rapid increase in the use of oral antidiabetic drugs in the United States, 1990-2001
    Diane K Wysowski
    Office of Drug Safety, Food and Drug Administration, Rockville, Maryland 20857, USA
    Diabetes Care 26:1852-5. 2003
    ..To describe the use of oral antidiabetic drugs for management of type 2 diabetes in the U.S. from 1990 through 2001...
  12. ncbi request reprint Sex and age differences in serum potassium in the United States
    Diane K Wysowski
    Office of Drug Safety, Food and Drug Administration, Rockville, MD 20857, USA
    Clin Chem 49:190-2. 2003
  13. ncbi request reprint Use of inhalant medications with and without chlorofluorocarbon propellants in the United States, 1996-2000
    Diane K Wysowski
    Division of Drug Risk Evaluation, Office of Drug Safety, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD 20857, USA
    J Allergy Clin Immunol 110:51-3. 2002
  14. pmc Analyzing prescription drugs as causes of death on death certificates
    Diane K Wysowski
    Public Health Rep 119:520. 2004
  15. ncbi request reprint Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients
    James L Mills
    National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, 6100 Building Room 7B03, Bethesda, MD 20892, USA
    J Pediatr 144:430-6. 2004
    ..We investigated whether they were at increased risk of death from other conditions, particularly preventable conditions...